{
  "meta": {
    "title": "Lipids",
    "url": "https://brainandscalpel.vercel.app/lipids-9bc34d2c.html",
    "scrapedAt": "2025-11-30T07:37:11.889Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Lecithin</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Cephalin</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphotidyl Inositol</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiolipin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which phospholipid is involved in blood coagulation?</span></p>",
      "unique_key": "DT1295619",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295619,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Lecithin (Phosphatidylcholine, PC):</strong>\r\n<ul>\r\n<li>Most abundant in cell membranes, particularly in the outer leaflet.</li>\r\n<li>Involved in membrane integrity and as a surfactant in the lungs to reduce surface tension.</li>\r\n<li>Not directly involved in blood coagulation.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Cephalin (Phosphatidylethanolamine, PE):</strong>\r\n<ul>\r\n<li>Found in biological membranes, especially in the inner leaflet and nervous tissue.</li>\r\n<li>Crucial for blood coagulation as it provides a surface for clotting factor assembly.</li>\r\n<li>Part of thromboplastin, which aids in clot formation.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Phosphatidylinositol (PI):</strong>\r\n<ul>\r\n<li>Plays a vital role in signaling pathways, but not involved in blood coagulation.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Cardiolipin:</strong>\r\n<ul>\r\n<li>Primarily stabilizes mitochondrial membranes and is essential for ATP production and the electron transport chain.</li>\r\n<li>Not involved in blood coagulation.</li>\r\n</ul></li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>a) Lecithin:</strong>\r\n<ul>\r\n<li><strong>Reason:</strong> Important in membrane structure and lung function, but not involved in blood coagulation.</li>\r\n</ul>\r\n</li>\r\n<li><strong>b) Phosphatidylinositol:</strong>\r\n<ul>\r\n<li><strong>Reason:</strong> Functions in cellular signaling, not in coagulation processes.</li>\r\n</ul>\r\n</li>\r\n<li><strong>c) Cardiolipin:</strong>\r\n<ul>\r\n<li><strong>Reason:</strong> Involved in mitochondrial function and energy production, not blood coagulation.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Phospholipids are amphipathic molecules crucial for various cellular processes.</li>\r\n<li><strong>Cephalin (Phosphatidylethanolamine)</strong> is vital for blood coagulation by acting as a surface for clotting factor assembly.</li>\r\n<li><strong>Lecithin</strong> plays a major role in maintaining membrane integrity and lung surfactant.</li>\r\n<li><strong>Cardiolipin</strong> stabilizes mitochondrial membranes, essential for energy production.</li>\r\n<li><strong>Phosphatidylinositol</strong> is involved in critical signaling pathways, not coagulation.</li>\r\n</ul>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Fetal heart maturity.</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Fetal lung maturity.</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Maternal Hypertension.</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Gestational diabetes.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Lecithin: Sphingomyelin (L:S) ratio in amniotic fluid is an important indicator used to evaluate</span></p>",
      "unique_key": "DT1295820",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295820,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Option A (Fetal heart maturity):</strong> The L:S ratio does not reflect fetal heart development. Fetal heart maturity is assessed through echocardiography or heart rate monitoring, not the L:S ratio.</li>\r\n<li><strong>Option B (Fetal lung maturity):</strong> The L:S ratio evaluates <strong>fetal lung maturity</strong> by comparing lecithin to sphingomyelin in amniotic fluid. Lecithin is a key surfactant component, which helps keep the lungs open by preventing alveolar collapse. As the fetus&rsquo;s lungs mature, lecithin levels rise while sphingomyelin levels remain constant. A <strong>L:S ratio of &ge; 2:1</strong> is considered indicative of lung maturity and lower risk of <strong>respiratory distress syndrome (RDS)</strong> at birth.</li>\r\n<li><strong>Option C (Maternal Hypertension):</strong> The L:S ratio does not assess maternal health conditions like hypertension. Maternal hypertension is monitored via blood pressure and other maternal health assessments.</li>\r\n<li><strong>Option D (Gestational diabetes):</strong> The L:S ratio is unrelated to gestational diabetes, which is diagnosed through glucose tolerance tests. Although gestational diabetes can affect fetal growth, it does not directly impact lung maturity measured by the L:S ratio.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (Fetal heart maturity):</strong> L:S ratio only indicates lung maturity, not heart function.</li>\r\n<li><strong>Option C (Maternal Hypertension):</strong> Maternal hypertension is assessed separately and is not related to L:S ratio.</li>\r\n<li><strong>Option D (Gestational diabetes):</strong> Gestational diabetes affects glucose metabolism, not lung maturity, making the L:S ratio irrelevant for diagnosis.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Lecithin</strong> (especially <strong>Dipalmitoyl lecithin</strong>) is essential for lung surfactant, which prevents alveolar collapse and aids breathing.</li>\r\n<li>A <strong>high L:S ratio (&ge; 2:1)</strong> indicates <strong>fetal lung maturity</strong>, reducing the risk of <strong>respiratory distress syndrome (RDS)</strong>.</li>\r\n<li><strong>Low L:S ratio (&lt; 2:1)</strong> suggests immature lungs, increasing the likelihood of <strong>RDS</strong> in preterm infants.</li>\r\n</ul>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholera toxin</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetanus toxin</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Rotavirus</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Influenza virus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Gangliosides can bind with viruses and toxins like</span></p>",
      "unique_key": "DT1295823",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295823,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Cholera toxin</strong>:\r\n<ul>\r\n<li>Binds to <strong>GM1 gangliosides</strong> in the <strong>intestines</strong>.</li>\r\n<li>Results in <strong>adenylate cyclase activation</strong>, leading to <strong>increased cAMP</strong>, which causes <strong>water loss</strong> from epithelial cells, resulting in <strong>severe diarrhea</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Tetanus toxin</strong>:\r\n<ul>\r\n<li>Binds to <strong>GT1b</strong> and <strong>GD1b gangliosides</strong> in the <strong>central nervous system</strong>.</li>\r\n<li>Prevents the release of inhibitory neurotransmitters like <strong>glycine</strong> and <strong>GABA</strong>, leading to <strong>spastic paralysis</strong> and <strong>muscle spasms</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Rotavirus</strong>:\r\n<ul>\r\n<li>Binds to <strong>GM1</strong> and <strong>GM3 gangliosides</strong> on <strong>intestinal epithelial cells</strong>.</li>\r\n<li>Causes <strong>gastroenteritis</strong>, leading to <strong>vomiting</strong>, <strong>diarrhea</strong>, and <strong>fever</strong>, primarily in <strong>young children</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Influenza virus</strong>:\r\n<ul>\r\n<li>Binds to <strong>sialic acid-containing gangliosides</strong> like <strong>GM3</strong> on <strong>respiratory epithelial cells</strong>.</li>\r\n<li>Facilitates entry of the virus into the cells, leading to <strong>respiratory infections</strong> like <strong>flu</strong> and <strong>bronchitis</strong>.</li>\r\n<li>Gangliosides assist in viral <strong>attachment</strong> and <strong>internalization</strong>.</li>\r\n</ul></li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li>All options are correct, as each toxin/virus specifically binds to different gangliosides, which are essential for their entry and effects on host cells.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Gangliosides serve as critical receptors for various <strong>toxins</strong> and <strong>viruses</strong>.</li>\r\n<li><strong>Cholera toxin</strong>, <strong>tetanus toxin</strong>, <strong>rotavirus</strong>, and <strong>influenza virus</strong> all utilize specific ganglioside receptors, causing a range of symptoms from <strong>gastroenteritis</strong> to <strong>respiratory infections</strong>.</li>\r\n</ul>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Micelles</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Liposomes</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Biological membranes</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycolipids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following structure of amphipathic lipids is involved in gene transfer?</span></p>",
      "unique_key": "DT1295825",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295825,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Micelles</strong>:\r\n<ul>\r\n<li>Spherical structures formed by amphipathic lipids, with hydrophobic tails facing inward and hydrophilic heads facing outward.</li>\r\n<li>Micelles lack the <strong>aqueous core</strong> required for encapsulating genetic material, making them unsuitable for <strong>gene transfer</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Liposomes</strong>:\r\n<ul>\r\n<li>Spherical vesicles with <strong>one or more lipid bilayers</strong>, containing an <strong>aqueous core</strong>.</li>\r\n<li>The <strong>aqueous core</strong> can encapsulate <strong>water-soluble substances</strong> like DNA or RNA.</li>\r\n<li>Liposomes are key in <strong>gene delivery</strong> systems, as they can <strong>fuse with cell membranes</strong> and deliver genetic material into cells, making them essential in <strong>gene therapy</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Biological membranes</strong>:\r\n<ul>\r\n<li>Composed of <strong>phospholipids</strong>, <strong>cholesterol</strong>, and <strong>proteins</strong>, these membranes separate the internal contents of a cell from its external environment.</li>\r\n<li>Though involved in cellular functions like endocytosis, biological membranes are not specifically designed for gene delivery.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Glycolipids</strong>:\r\n<ul>\r\n<li>Lipids with a <strong>carbohydrate group</strong> attached, found in the outer leaflet of the <strong>cell membrane</strong>.</li>\r\n<li><strong>Glycolipids</strong> play a role in <strong>cell recognition</strong> and <strong>signaling</strong>, but do not directly contribute to <strong>gene transfer</strong>.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Micelles</strong> (A): Too small and lack the structural capacity to encapsulate genetic material.</li>\r\n<li><strong>Biological membranes</strong> (C): While essential for cellular function, they are not specifically involved in gene delivery.</li>\r\n<li><strong>Glycolipids</strong> (D): Primarily involved in <strong>cell recognition</strong> and <strong>immune responses</strong>, not in <strong>gene transfer</strong>.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Amphipathic lipids</strong> have both <strong>hydrophilic</strong> and <strong>hydrophobic</strong> regions, allowing them to form structures like <strong>micelles</strong>, <strong>liposomes</strong>, and <strong>biological membranes</strong>.</li>\r\n<li><strong>Liposomes</strong> are crucial in <strong>gene transfer</strong> due to their ability to <strong>encapsulate genetic material</strong> and deliver it to cells.</li>\r\n<li><strong>Micelles</strong> are involved in <strong>lipid absorption</strong> but are not suitable for <strong>gene transfer</strong>.</li>\r\n<li><strong>Glycolipids</strong> are important for <strong>cell communication</strong> but do not play a role in <strong>genetic material delivery</strong>.</li>\r\n</ul>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">It occurs due to defect in ABC (ATP binding cassette transporter) protein</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">It increases the risk of coronary heart disease.</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Orange colour tonsils are seen in this disease</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">It occurs due to deficiency of Lipoprotein lipase enzyme (LPL).</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are characteristics of Tangier disease, except</span></p>",
      "unique_key": "DT1295830",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295830,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Option A:</strong>\r\n<ul>\r\n<li>Tangier disease is caused by mutations in the <strong>ABCA1 gene</strong>, which encodes an <strong>ATP-binding cassette (ABC) transporter</strong>.</li>\r\n<li>This protein is essential for transferring <strong>cholesterol</strong> and <strong>phospholipids</strong> to <strong>apolipoprotein A-I</strong>, a critical component in the formation of <strong>HDL</strong> (good cholesterol).</li>\r\n<li>Defective ABCA1 transporters lead to impaired cholesterol export, resulting in the symptoms of Tangier disease.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option B:</strong>\r\n<ul>\r\n<li>Due to the <strong>deficient HDL levels</strong> in Tangier disease, individuals are at an increased risk for <strong>atherosclerosis</strong> and <strong>coronary heart disease</strong>.</li>\r\n<li>HDL helps remove cholesterol from the bloodstream, and a reduction in HDL increases the accumulation of cholesterol in the arteries.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option C:</strong>\r\n<ul>\r\n<li>A hallmark feature of Tangier disease is the <strong>orange-coloured tonsils</strong>, which occur due to the <strong>accumulation of cholesterol and lipids</strong> in lymphatic tissues, particularly the tonsils.</li>\r\n<li>This feature helps in diagnosing the disease and is considered a significant clinical sign.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option D:</strong>\r\n<ul>\r\n<li><strong>Lipoprotein lipase (LPL)</strong> deficiency is not the cause of Tangier disease.</li>\r\n<li><strong>LPL</strong> is an enzyme responsible for breaking down triglycerides in lipoproteins like VLDL and chylomicrons, and its deficiency leads to a condition known as <strong>familial chylomicronaemia syndrome</strong>, which is different from Tangier disease, characterized by <strong>high triglycerides</strong> and <strong>not low HDL</strong>.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A:</strong> Correct. Tangier disease is caused by mutations in the <strong>ABCA1 gene</strong>, leading to <strong>low HDL levels</strong>.</li>\r\n<li><strong>Option B:</strong> Correct. <strong>Low HDL</strong> levels increase the risk of <strong>atherosclerosis</strong> and <strong>coronary heart disease</strong>.</li>\r\n<li><strong>Option C:</strong> Correct. <strong>Orange-coloured tonsils</strong> are a classic sign of <strong>cholesterol accumulation</strong> in Tangier disease.</li>\r\n<li><strong>Option D:</strong> Incorrect. Tangier disease is not caused by <strong>LPL deficiency</strong>; it&rsquo;s caused by an issue with the <strong>ABCA1 gene</strong>.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Tangier disease</strong> is an <strong>autosomal recessive disorder</strong> caused by mutations in the <strong>ABCA1 gene</strong>, leading to <strong>deficient HDL</strong> production.</li>\r\n<li>This condition results in <strong>cholesterol accumulation</strong> in various tissues, contributing to <strong>atherosclerosis</strong> and <strong>coronary heart disease</strong>.</li>\r\n<li>A key feature of Tangier disease is <strong>orange-coloured tonsils</strong>, a result of <strong>lipid buildup</strong> in lymphatic tissues.</li>\r\n<li><strong>LPL deficiency</strong> is unrelated to Tangier disease, and instead causes <strong>familial chylomicronaemia syndrome</strong>, which is marked by <strong>high triglycerides</strong>, not low HDL.</li>\r\n</ul>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Chylomicrons</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">VLDL</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">LDL</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">HDL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which lipoprotein is primarily involved in the transport of endogenous triglycerides?</span></p>",
      "unique_key": "DT1295831",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295831,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Option A:</strong>\r\n<ul>\r\n<li><strong>Chylomicrons</strong> are the largest lipoproteins, primarily responsible for transporting <strong>dietary (exogenous)</strong> triglycerides and cholesterol from the intestines to peripheral tissues and the liver.</li>\r\n<li>They carry triglycerides from food, not those synthesized by the liver (endogenous).</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option B:</strong>\r\n<ul>\r\n<li><strong>VLDL</strong> (Very Low-Density Lipoprotein) is produced in the <strong>liver</strong> and is the primary lipoprotein responsible for transporting <strong>endogenous triglycerides</strong> (triglycerides synthesized in the liver) to peripheral tissues, including <strong>muscle</strong> and <strong>adipose tissue</strong>.</li>\r\n<li>These triglycerides are produced in the liver and delivered to tissues for storage or energy use.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option C:</strong>\r\n<ul>\r\n<li><strong>LDL</strong> (Low-Density Lipoprotein) is primarily involved in transporting <strong>cholesterol</strong> to peripheral tissues.</li>\r\n<li>After <strong>VLDL</strong> loses its triglycerides, it becomes LDL, which is primarily composed of <strong>cholesterol</strong>, not triglycerides.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option D:</strong>\r\n<ul>\r\n<li><strong>HDL</strong> (High-Density Lipoprotein) is involved in <strong>reverse cholesterol transport</strong>, removing <strong>excess cholesterol</strong> from tissues and returning it to the liver for excretion.</li>\r\n<li>It does not transport triglycerides.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A:</strong> Incorrect. <strong>Chylomicrons</strong> transport <strong>dietary triglycerides</strong> (exogenous), not <strong>endogenous triglycerides</strong> synthesized by the liver.</li>\r\n<li><strong>Option B:</strong> Correct. <strong>VLDL</strong> is primarily involved in transporting <strong>endogenous triglycerides</strong> from the liver to tissues.</li>\r\n<li><strong>Option C:</strong> Incorrect. <strong>LDL</strong> mainly transports <strong>cholesterol</strong>, not triglycerides, to peripheral tissues.</li>\r\n<li><strong>Option D:</strong> Incorrect. <strong>HDL</strong> is involved in <strong>reverse cholesterol transport</strong>, not triglyceride transport.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Chylomicrons</strong> transport <strong>dietary (exogenous)</strong> triglycerides from the intestine to peripheral tissues.</li>\r\n<li><strong>VLDL</strong> transports <strong>endogenous triglycerides</strong> from the liver to peripheral tissues.</li>\r\n<li><strong>LDL</strong> is primarily involved in transporting <strong>cholesterol</strong> to peripheral tissues.</li>\r\n<li><strong>HDL</strong> is involved in <strong>reverse cholesterol transport</strong>, removing excess cholesterol from tissues and returning it to the liver.</li>\r\n</ul>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucagon</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid hormone</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following hormones promotes lipolysis in adipose tissue, except:</span></p>",
      "unique_key": "DT1295832",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295832,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Insulin</strong>: The \"storage hormone\" of the body, insulin is released when blood glucose is high. It inhibits lipolysis by activating enzymes like lipoprotein lipase (LPL) to store fat, and it also suppresses hormone-sensitive lipase (HSL), the enzyme that breaks down stored fat into free fatty acids and glycerol.</li>\r\n<li><strong>Glucagon</strong>: The \"fasting hormone,\" glucagon is secreted during low blood glucose levels. It promotes lipolysis by activating hormone-sensitive lipase (HSL), which breaks down triglycerides in adipose tissue into free fatty acids, supplying energy during fasting or exercise.</li>\r\n<li><strong>Thyroid hormone</strong>: The \"metabolism booster,\" thyroid hormones increase the body's basal metabolic rate and enhance the sensitivity of adipose tissue to lipolytic hormones like catecholamines (e.g., epinephrine), stimulating fat breakdown to meet increased energy demands.</li>\r\n<li><strong>Growth hormone (GH)</strong>: The \"fat-burning hormone,\" GH stimulates lipolysis by increasing the activity of hormone-sensitive lipase (HSL), breaking down stored fat and helping release free fatty acids for energy, while also reducing insulin's fat-storing effect.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (Insulin)</strong>: <strong>Inhibits lipolysis</strong> by promoting fat storage through LPL activation and suppressing HSL activity.</li>\r\n<li><strong>Option B (Glucagon)</strong>: <strong>Promotes lipolysis</strong> by activating HSL, especially during fasting or low glucose conditions.</li>\r\n<li><strong>Option C (Thyroid hormone)</strong>: <strong>Indirectly promotes lipolysis</strong> by boosting metabolic rate and increasing fat breakdown sensitivity.</li>\r\n<li><strong>Option D (Growth hormone)</strong>: <strong>Promotes lipolysis</strong> by enhancing fat breakdown through increased HSL activity, helping release free fatty acids from fat stores.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Insulin:</strong> \"Storage hormone\" that inhibits lipolysis and promotes fat storage.</li>\r\n<li><strong>Glucagon:</strong> \"Fasting hormone\" that promotes lipolysis during low blood sugar by activating HSL.</li>\r\n<li><strong>Thyroid hormone:</strong> \"Metabolism booster\" that indirectly promotes lipolysis by increasing metabolic rate.</li>\r\n<li><strong>Growth hormone:</strong> \"Fat-burning hormone\" that promotes lipolysis and releases free fatty acids by activating HSL.</li>\r\n</ul>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetyl-CoA carboxylase</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Fatty acid synthase</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Hormone-sensitive lipase</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Citrate lyase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the key regulatory enzyme in the synthesis of fatty acids from acetyl-CoA?</span></p>",
      "unique_key": "DT1295833",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295833,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Acetyl-CoA carboxylase (ACC)</strong>: The key regulatory enzyme in fatty acid synthesis. It catalyzes the conversion of acetyl-CoA to malonyl-CoA, a crucial intermediate that initiates the process of fatty acid synthesis. This is the first committed step, regulating the rate of fatty acid production.</li>\r\n<li><strong>Fatty acid synthase (FAS)</strong>: This multi-enzyme complex catalyzes the sequential addition of two-carbon units from malonyl-CoA to elongate the growing fatty acid chain. However, it is not the key enzyme; its role is more about elongating the fatty acid rather than regulating the initial step.</li>\r\n<li><strong>Hormone-sensitive lipase (HSL)</strong>: Involved in lipolysis, breaking down triglycerides into free fatty acids and glycerol. It is not involved in fatty acid synthesis but rather in the mobilization of stored fats during fasting or energy demand.</li>\r\n<li><strong>Citrate lyase</strong>: Converts citrate into acetyl-CoA and oxaloacetate in the cytoplasm, providing acetyl-CoA for fatty acid synthesis. While it supplies acetyl-CoA, it is not the regulatory enzyme for fatty acid synthesis.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (Acetyl-CoA carboxylase)</strong>: <strong>Key regulatory enzyme</strong> in fatty acid synthesis, converting acetyl-CoA to malonyl-CoA.</li>\r\n<li><strong>Option B (Fatty acid synthase)</strong>: <strong>Catalyzes elongation</strong> of fatty acids but does not regulate the overall process.</li>\r\n<li><strong>Option C (Hormone-sensitive lipase)</strong>: <strong>Involved in lipolysis</strong>, not in fatty acid synthesis.</li>\r\n<li><strong>Option D (Citrate lyase)</strong>: <strong>Provides acetyl-CoA</strong> for fatty acid synthesis but is not the regulatory enzyme.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Acetyl-CoA carboxylase</strong>: Key enzyme, converts acetyl-CoA to malonyl-CoA, starting fatty acid synthesis.</li>\r\n<li><strong>Fatty acid synthase</strong>: Involved in fatty acid chain elongation, not regulation.</li>\r\n<li><strong>Hormone-sensitive lipase</strong>: Breaks down triglycerides during lipolysis, not involved in synthesis.</li>\r\n<li><strong>Citrate lyase</strong>: Supplies acetyl-CoA, but not a regulatory enzyme.</li>\r\n</ul>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Cortisol</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Epinephrine</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Both B and C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following hormones is responsible for activating lipolysis?</span></p>",
      "unique_key": "DT1295835",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295835,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Insulin</strong>: Secreted by the pancreas in response to high blood glucose levels, insulin primarily promotes the storage of glucose as glycogen or fat. It inhibits lipolysis in adipose tissue by activating enzymes like lipoprotein lipase, which promote fat storage, and suppressing the activity of hormone-sensitive lipase (HSL), which breaks down fats.</li>\r\n<li><strong>Cortisol</strong>: A glucocorticoid hormone released during stress, cortisol helps increase blood sugar by promoting gluconeogenesis. It can indirectly promote lipolysis by increasing the availability of fatty acids to provide energy during prolonged stress.</li>\r\n<li><strong>Epinephrine</strong>: Known as adrenaline, this hormone is released during the \"fight or flight\" response. Epinephrine directly activates lipolysis by binding to &beta;-adrenergic receptors on fat cells, triggering the breakdown of triglycerides into free fatty acids and glycerol for energy.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (Insulin)</strong>: <strong>Inhibits lipolysis</strong> and promotes fat storage by suppressing hormone-sensitive lipase.</li>\r\n<li><strong>Option B (Cortisol)</strong>: <strong>Promotes lipolysis</strong> indirectly by increasing fatty acid availability during stress.</li>\r\n<li><strong>Option C (Epinephrine)</strong>: <strong>Directly activates lipolysis</strong> through &beta;-adrenergic receptors, leading to the breakdown of fats.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Insulin</strong>: Inhibits lipolysis, promotes fat storage.</li>\r\n<li><strong>Cortisol</strong>: Promotes lipolysis indirectly by increasing fatty acid availability during stress.</li>\r\n<li><strong>Epinephrine</strong>: Directly activates lipolysis through &beta;-adrenergic receptors.</li>\r\n<li><strong>Hormones promoting lipolysis</strong>: Cortisol, Epinephrine, Glucagon, Catecholamines, Growth hormone, Thyroid hormones.</li>\r\n</ul>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits fatty acid oxidation</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulates lipolysis</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Converts fatty acids to triglycerides</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What role does malonyl-CoA play in fatty acid metabolism?</span></p>",
      "unique_key": "DT1295843",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295843,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Malonyl-CoA and Fatty Acid Oxidation</strong>: Malonyl-CoA inhibits fatty acid oxidation by blocking <strong>carnitine palmitoyltransferase I (CPT-1)</strong>, the enzyme responsible for transporting fatty acids into mitochondria for <strong>&beta;-oxidation</strong>. When <strong>malonyl-CoA</strong> levels are high, fatty acid breakdown is suppressed, preventing the degradation of fatty acids in the mitochondria. This ensures that fatty acid synthesis and oxidation do not occur simultaneously.</li>\r\n<li><strong>Malonyl-CoA and Fatty Acid Synthesis</strong>: Malonyl-CoA is a key intermediate in <strong>fatty acid synthesis</strong>. It is synthesized from <strong>acetyl-CoA</strong> by <strong>acetyl-CoA carboxylase (ACC)</strong>, and it is used in the elongation process of fatty acid chains. High levels of malonyl-CoA signal the body to <strong>synthesize fatty acids</strong> rather than break them down.</li>\r\n<li><strong>Malonyl-CoA and Lipolysis</strong>: Malonyl-CoA does not directly stimulate <strong>lipolysis</strong> (the breakdown of triglycerides). Lipolysis is mainly regulated by hormones like <strong>epinephrine</strong>, not malonyl-CoA.</li>\r\n<li><strong>Malonyl-CoA and Triglyceride Formation</strong>: Malonyl-CoA is involved in fatty acid synthesis but does not directly convert fatty acids into <strong>triglycerides</strong>. <strong>Triglyceride formation</strong> involves the esterification of fatty acids with <strong>glycerol</strong>, which is separate from the role of malonyl-CoA.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option C (Stimulates lipolysis)</strong>: Malonyl-CoA does <strong>not</strong> stimulate lipolysis, which is controlled by other hormones like epinephrine.</li>\r\n<li><strong>Option D (Converts fatty acids to triglycerides)</strong>: Malonyl-CoA does <strong>not</strong> directly mediate the conversion of fatty acids to triglycerides; it promotes fatty acid synthesis.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Malonyl-CoA</strong>: Inhibits fatty acid oxidation and activates fatty acid synthesis.</li>\r\n<li><strong>Fatty acid synthesis</strong>: Occurs in the cytoplasm, using <strong>acetyl-CoA</strong> and <strong>NADPH</strong>.</li>\r\n<li><strong>Acetyl-CoA carboxylase (ACC)</strong>: Converts <strong>acetyl-CoA</strong> into <strong>malonyl-CoA</strong>, the key regulatory step in fatty acid synthesis.</li>\r\n<li><strong>Fatty acid synthesis</strong> is promoted during fed states and inhibited during fasting.</li>\r\n</ul>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetyl-CoA</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">NADH</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">FADH2</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is NOT a product of fatty acid beta-oxidation?</span></p>",
      "unique_key": "DT1295844",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295844,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Acetyl-CoA</strong>: Acetyl-CoA is a primary product of <strong>fatty acid beta-oxidation</strong>. During this process, two-carbon units are cleaved from the fatty acid chain to form <strong>acetyl-CoA</strong>, which then enters the <strong>citric acid cycle</strong> (Krebs cycle) for further oxidation and energy production or can be used for ketone body formation during prolonged fasting.</li>\r\n<li><strong>NADH</strong>: <strong>NADH</strong> is produced in one of the oxidation steps of <strong>beta-oxidation</strong>. Specifically, it is generated when <strong>3-hydroxyacyl-CoA</strong> is oxidized to <strong>3-ketoacyl-CoA</strong>. <strong>NADH</strong> serves as an electron carrier, donating electrons to the <strong>electron transport chain (ETC)</strong> and producing ATP.</li>\r\n<li><strong>FADH2</strong>: <strong>FADH2</strong> is also a product of beta-oxidation, produced when <strong>acyl-CoA</strong> is dehydrogenated to form <strong>trans-enoyl-CoA</strong>. Like <strong>NADH</strong>, <strong>FADH2</strong> donates electrons to the <strong>ETC</strong> to generate ATP.</li>\r\n<li><strong>Glucose</strong>: <strong>Glucose</strong> is <strong>not</strong> a product of fatty acid beta-oxidation. Fatty acid breakdown produces <strong>acetyl-CoA</strong>, <strong>NADH</strong>, and <strong>FADH2</strong>, but glucose comes from carbohydrate metabolism through processes like <strong>glycogenolysis</strong> and <strong>gluconeogenesis</strong>. Fatty acids cannot be converted back into glucose, as the pathway is irreversible once acetyl-CoA is formed.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (Acetyl-CoA)</strong>: <strong>Acetyl-CoA</strong> is a direct and important product of <strong>beta-oxidation</strong>, which enters the citric acid cycle for energy production.</li>\r\n<li><strong>Option B (NADH)</strong>: <strong>NADH</strong> is generated in the <strong>beta-oxidation</strong> cycle and is used to produce ATP via the electron transport chain.</li>\r\n<li><strong>Option C (FADH2)</strong>: <strong>FADH2</strong> is another key product of <strong>beta-oxidation</strong>, which also donates electrons to the electron transport chain to produce ATP.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Fatty acid beta-oxidation</strong> yields <strong>acetyl-CoA</strong>, <strong>NADH</strong>, and <strong>FADH2</strong>.</li>\r\n<li><strong>Fatty acids</strong> cannot be converted into <strong>glucose</strong> in humans.</li>\r\n</ul>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Phospholipids</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Triglycerides</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholesterol</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Fatty acids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which lipid is a precursor for steroid hormones?</span></p>",
      "unique_key": "DT1295873",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295873,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Phospholipids</strong>: These are vital components of cell membranes, forming the lipid bilayer that separates the cell's internal environment from the outside world. They do not directly participate in the synthesis of steroid hormones.</li>\r\n<li><strong>Triglycerides</strong>: These are the primary storage form of fats in the body, consisting of glycerol and three fatty acids. They serve mainly as an energy reserve and are broken down during lipolysis to release fatty acids for energy production, not for steroid hormone synthesis.</li>\r\n<li><strong>Cholesterol</strong>: <strong>Cholesterol</strong> is the direct precursor for the synthesis of all steroid hormones. It is used to produce important hormones like <strong>cortisol</strong>, <strong>aldosterone</strong>, <strong>testosterone</strong>, <strong>estrogen</strong>, and <strong>progesterone</strong>. Cholesterol is first converted into <strong>pregnenolone</strong>, the first step in the steroid hormone production pathway.</li>\r\n<li><strong>Fatty acids</strong>: <strong>Fatty acids</strong> are primarily involved in energy storage and serve as the building blocks of lipids like triglycerides and phospholipids. They are important for energy production through <strong>beta-oxidation</strong> but are not directly involved in the synthesis of steroid hormones.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (Phospholipids)</strong>: <strong>Phospholipids</strong> are essential for <strong>membrane structure</strong> and <strong>cell function</strong>, not for steroid hormone synthesis.</li>\r\n<li><strong>Option B (Triglycerides)</strong>: <strong>Triglycerides</strong> store energy and do not contribute to the synthesis of steroid hormones.</li>\r\n<li><strong>Option D (Fatty acids)</strong>: <strong>Fatty acids</strong> are crucial for <strong>energy metabolism</strong> and lipid synthesis but are not precursors for steroid hormones.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Phospholipids</strong>: Main components of cell membranes.</li>\r\n<li><strong>Triglycerides</strong>: Energy storage form of fats.</li>\r\n<li><strong>Cholesterol</strong>: Direct precursor for all steroid hormones.</li>\r\n<li><strong>Fatty acids</strong>: Involved in <strong>energy storage</strong> and <strong>production</strong>.</li>\r\n</ul>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta-hydroxybutyrate dehydrogenase</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetyl-CoA carboxylase</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">HMG-CoA lyase</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">HMG-CoA reductase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which enzyme catalyzes the conversion of acetoacetate to beta-hydroxybutyrate?</span></p>",
      "unique_key": "DT1295877",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295877,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Beta-hydroxybutyrate dehydrogenase</strong>: This enzyme catalyzes the <strong>reversible conversion</strong> of <strong>acetoacetate</strong> to <strong>beta-hydroxybutyrate</strong> during <strong>ketogenesis</strong>. The reaction requires <strong>NADH</strong> as a cofactor, which reduces acetoacetate into beta-hydroxybutyrate. Ketone bodies, including acetoacetate and beta-hydroxybutyrate, are produced during fasting or low-carb diets and serve as alternative energy sources.</li>\r\n<li><strong>Acetyl-CoA carboxylase</strong>: This enzyme is key in <strong>fatty acid synthesis</strong>. It catalyzes the conversion of <strong>acetyl-CoA</strong> to <strong>malonyl-CoA</strong>. This enzyme is not involved in ketogenesis but in regulating fatty acid synthesis by controlling the rate-limiting step.</li>\r\n<li><strong>HMG-CoA lyase</strong>: This enzyme catalyzes the cleavage of <strong>HMG-CoA</strong> (3-hydroxy-3-methylglutaryl-CoA) into <strong>acetoacetate</strong> and <strong>acetyl-CoA</strong> during <strong>ketogenesis</strong>. It plays a critical role in the generation of acetoacetate, one of the key ketone bodies, but not in the conversion of acetoacetate to beta-hydroxybutyrate.</li>\r\n<li><strong>HMG-CoA reductase</strong>: This enzyme is involved in <strong>cholesterol synthesis</strong>, converting <strong>HMG-CoA</strong> to <strong>mevalonate</strong>. It is not involved in ketogenesis. It plays a regulatory role in cholesterol production and is the target of statins for reducing cholesterol levels.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option B (Acetyl-CoA carboxylase)</strong>: This enzyme is involved in fatty acid synthesis, not ketogenesis or the conversion of acetoacetate to beta-hydroxybutyrate.</li>\r\n<li><strong>Option C (HMG-CoA lyase)</strong>: While this enzyme is involved in ketogenesis, it cleaves <strong>HMG-CoA</strong> to produce <strong>acetoacetate</strong>, not in converting <strong>acetoacetate</strong> to <strong>beta-hydroxybutyrate</strong>.</li>\r\n<li><strong>Option D (HMG-CoA reductase)</strong>: This enzyme is involved in <strong>cholesterol biosynthesis</strong>, not ketogenesis or the conversion of acetoacetate to beta-hydroxybutyrate.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Acetyl-CoA carboxylase</strong>: Key enzyme in <strong>fatty acid synthesis</strong>.</li>\r\n<li><strong>HMG-CoA lyase</strong>: Produces <strong>acetoacetate</strong> in <strong>ketogenesis</strong>.</li>\r\n<li><strong>HMG-CoA reductase</strong>: Involved in <strong>cholesterol synthesis</strong>.</li>\r\n<li><strong>Beta-hydroxybutyrate dehydrogenase</strong>: Converts <strong>acetoacetate to beta-hydroxybutyrate</strong> in <strong>ketogenesis</strong>.</li>\r\n</ul>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaucher disease</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Niemann-Pick disease</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Tay-Sachs disease</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Fabry disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is characterized by the accumulation of sphingomyelin in cells?</span></p>",
      "unique_key": "DT1295879",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295879,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Gaucher Disease</strong>: Caused by a deficiency in <strong>glucocerebrosidase</strong>, leading to the accumulation of <strong>glucocerebroside</strong> in <strong>lysosomes</strong>. It causes symptoms like <strong>hepatosplenomegaly</strong>, <strong>bone pain</strong>, and <strong>neurological issues</strong> in some types.</li>\r\n<li><strong>Niemann-Pick Disease</strong>: Caused by a deficiency in <strong>sphingomyelinase</strong>, leading to the accumulation of <strong>sphingomyelin</strong> in <strong>cells</strong>, especially in the <strong>liver</strong>, <strong>spleen</strong>, and <strong>brain</strong>. Symptoms include <strong>organ enlargement</strong>, <strong>developmental delay</strong>, and <strong>neurological issues</strong>.</li>\r\n<li><strong>Tay-Sachs Disease</strong>: Caused by a deficiency in <strong>hexosaminidase A</strong>, resulting in the accumulation of <strong>GM2 gangliosides</strong> in the <strong>nervous system</strong>, leading to <strong>neurodegeneration</strong>, <strong>motor skill regression</strong>, and early death in severe cases.</li>\r\n<li><strong>Fabry Disease</strong>: Caused by a deficiency in <strong>alpha-galactosidase A</strong>, leading to the accumulation of <strong>globotriaosylceramide (Gb3)</strong> in <strong>cells</strong>, causing <strong>pain</strong> in the <strong>hands and feet</strong>, <strong>kidney problems</strong>, and <strong>skin lesions</strong>.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A (Gaucher Disease)</strong>: It involves the accumulation of <strong>glucocerebroside</strong>, not <strong>sphingomyelin</strong>.</li>\r\n<li><strong>Option C (Tay-Sachs Disease)</strong>: It involves the accumulation of <strong>GM2 gangliosides</strong>, not <strong>sphingomyelin</strong>.</li>\r\n<li><strong>Option D (Fabry Disease)</strong>: It involves the accumulation of <strong>globotriaosylceramide</strong>, not <strong>sphingomyelin</strong>.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Gaucher Disease</strong>: Deficiency in <strong>glucocerebrosidase</strong>, leading to the accumulation of <strong>glucocerebroside</strong>.</li>\r\n<li><strong>Niemann-Pick Disease</strong>: Deficiency in <strong>sphingomyelinase</strong>, leading to the accumulation of <strong>sphingomyelin</strong>.</li>\r\n<li><strong>Tay-Sachs Disease</strong>: Deficiency in <strong>hexosaminidase A</strong>, leading to the accumulation of <strong>GM2 gangliosides</strong>.</li>\r\n<li><strong>Fabry Disease</strong>: Deficiency in <strong>alpha-galactosidase A</strong>, leading to the accumulation of <strong>globotriaosylceramide (Gb3)</strong>.</li>\r\n</ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Niemann-Pick disease</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Tay-Sachs disease</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaucher disease</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Fabry disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with hepatosplenomegaly and developmental delays. Genetic testing reveals a deficiency in glucocerebrosidase. Which lipid storage disease does this suggest?</span></p>",
      "unique_key": "DT1295880",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295880,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Niemann-Pick Disease:</strong>\r\n<ul>\r\n<li>Caused by a deficiency in <strong>sphingomyelinase</strong>, leading to the accumulation of <strong>sphingomyelin</strong> in cells, particularly in the liver, spleen, and brain.</li>\r\n<li>Symptoms include <strong>hepatosplenomegaly</strong>, <strong>neurodegeneration</strong>, and a <strong>\"cherry-red\" macula</strong>.</li>\r\n<li><strong>Not linked</strong> to glucocerebrosidase deficiency.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Tay-Sachs Disease:</strong>\r\n<ul>\r\n<li>Caused by a deficiency in <strong>hexosaminidase A</strong>, leading to the accumulation of <strong>GM2 gangliosides</strong>.</li>\r\n<li>Symptoms include <strong>neurodegeneration</strong>, <strong>developmental delays</strong>, and a <strong>\"cherry-red\" macula</strong>.</li>\r\n<li><strong>Not related</strong> to glucocerebrosidase deficiency.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Gaucher Disease:</strong>\r\n<ul>\r\n<li><strong>Deficiency in glucocerebrosidase</strong>, leading to the accumulation of <strong>glucocerebroside</strong> in <strong>lysosomes</strong>.</li>\r\n<li>Symptoms include <strong>hepatosplenomegaly</strong>, <strong>bone pain</strong>, <strong>anemia</strong>, and <strong>thrombocytopenia</strong>.</li>\r\n<li><strong>Directly associated</strong> with glucocerebrosidase deficiency, matching the genetic test result.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Fabry Disease:</strong>\r\n<ul>\r\n<li>Caused by a deficiency in <strong>alpha-galactosidase A</strong>, leading to the accumulation of <strong>globotriaosyl ceramide</strong>.</li>\r\n<li>Symptoms include <strong>pain in the hands/feet</strong>, <strong>angiokeratomas</strong>, and <strong>renal and cardiac issues</strong>.</li>\r\n<li><strong>Not related</strong> to glucocerebrosidase deficiency.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Niemann-Pick Disease:</strong>\r\n<ul>\r\n<li>The enzyme <strong>sphingomyelinase</strong> is deficient, not glucocerebrosidase.</li>\r\n<li><strong>Not linked</strong> to glucocerebrosidase.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Tay-Sachs Disease:</strong>\r\n<ul>\r\n<li>Caused by a deficiency in <strong>hexosaminidase A</strong>, leading to <strong>GM2 ganglioside</strong> accumulation.</li>\r\n<li><strong>No connection</strong> to glucocerebrosidase.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Fabry Disease:</strong>\r\n<ul>\r\n<li>Caused by a deficiency in <strong>alpha-galactosidase A</strong>, leading to <strong>globotriaosyl ceramide</strong> accumulation.</li>\r\n<li><strong>Not associated</strong> with glucocerebrosidase.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Gaucher Disease</strong> is caused by <strong>glucocerebrosidase deficiency</strong>, leading to the accumulation of <strong>glucocerebroside</strong> in <strong>lysosomes</strong>.</li>\r\n<li>Symptoms include <strong>hepatosplenomegaly</strong>, <strong>bone pain</strong>, <strong>anemia</strong>, and <strong>thrombocytopenia</strong>.</li>\r\n<li>Other diseases like <strong>Niemann-Pick</strong>, <strong>Tay-Sachs</strong>, and <strong>Fabry</strong> involve different enzyme deficiencies and substrates.</li>\r\n</ul>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Neurological deficits</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Corneal opacities and kidney damage</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatosplenomegaly</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Bone pain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the primary clinical manifestation of Fabry disease?</span></p>",
      "unique_key": "DT1295881",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295881,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Neurological deficits:</strong>\r\n<ul>\r\n<li>Neurological symptoms, though present in some lysosomal storage disorders, <strong>are not the primary manifestation</strong> of Fabry disease.</li>\r\n<li><strong>Not the main feature</strong> of Fabry disease.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Corneal opacities and kidney damage:</strong>\r\n<ul>\r\n<li><strong>Corneal verticillata</strong> (whorl-like corneal opacities) and <strong>progressive kidney damage</strong> leading to <strong>chronic kidney disease</strong> and even <strong>renal failure</strong> are hallmark features of <strong>Fabry disease</strong>.</li>\r\n<li><strong>Primary clinical manifestations</strong> of Fabry disease.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Hepatosplenomegaly:</strong>\r\n<ul>\r\n<li>Not a prominent feature of <strong>Fabry disease</strong>.</li>\r\n<li><strong>More commonly associated</strong> with diseases like <strong>Gaucher</strong> and <strong>Niemann-Pick</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Bone pain:</strong>\r\n<ul>\r\n<li>Bone pain is a primary symptom in <strong>Gaucher disease</strong>, not in <strong>Fabry disease</strong>.</li>\r\n<li><strong>Not characteristic</strong> of Fabry disease.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A: Neurological deficits</strong>\r\n<ul>\r\n<li>Neurological deficits like <strong>neurodegeneration</strong> are <strong>not the primary feature</strong> of Fabry disease.</li>\r\n<li>Primary manifestations involve <strong>kidneys</strong>, <strong>heart</strong>, and <strong>skin</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option C: Hepatosplenomegaly</strong>\r\n<ul>\r\n<li><strong>Gaucher</strong> and <strong>Niemann-Pick</strong> diseases are associated with <strong>hepatosplenomegaly</strong>, not Fabry disease.</li>\r\n<li><strong>Not a prominent feature</strong> of Fabry disease.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option D: Bone pain</strong>\r\n<ul>\r\n<li><strong>Gaucher disease</strong> is more commonly associated with <strong>bone pain</strong>.</li>\r\n<li><strong>Fabry disease</strong> does not typically present with bone pain.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Fabry disease</strong> is a genetic <strong>lysosomal storage disorder</strong> caused by a deficiency of the enzyme <strong>alpha-galactosidase A</strong>.</li>\r\n<li>It follows an <strong>X-linked recessive</strong> inheritance pattern.</li>\r\n<li>Due to enzyme deficiency, <strong>globotriaosylceramide (Gb3)</strong> accumulates in tissues like <strong>kidneys</strong>, <strong>heart</strong>, and <strong>skin</strong>, leading to progressive damage.</li>\r\n<li><strong>Primary symptoms</strong> include <strong>corneal opacities</strong>, <strong>kidney damage</strong>, and <strong>neuropathic pain</strong> (acroparesthesias).</li>\r\n</ul>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Genetic mutation</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Excessive carbohydrate intake</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcohol consumption</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old woman reports persistent fatigue and weight gain despite a low-calorie diet. Laboratory tests reveal elevated triglycerides and a deficiency in lipoprotein lipase activity. What is the most likely underlying issue?</span></p>",
      "unique_key": "DT1295886",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295886,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Genetic mutation:</strong>\r\n<ul>\r\n<li><strong>Lipoprotein lipase (LPL) deficiency</strong> is most commonly due to a <strong>genetic mutation</strong> affecting the <strong>LPL gene</strong>.</li>\r\n<li><strong>LPL</strong> is responsible for breaking down triglycerides in lipoproteins, and a <strong>deficiency</strong> causes <strong>elevated triglycerides</strong> despite a controlled diet.</li>\r\n<li><strong>Key symptoms</strong> include <strong>fatigue</strong>, <strong>weight gain</strong>, and <strong>high triglyceride levels</strong> due to the inability to break down circulating triglycerides.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Excessive carbohydrate intake:</strong>\r\n<ul>\r\n<li>High carbohydrate intake can <strong>increase triglycerides</strong> by promoting <strong>endogenous triglyceride synthesis</strong>, but it does not <strong>cause a deficiency</strong> in <strong>LPL activity</strong>.</li>\r\n<li>Carbohydrate excess leads to increased <strong>triglyceride synthesis</strong>, not impaired breakdown due to <strong>LPL deficiency</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Alcohol consumption:</strong>\r\n<ul>\r\n<li>Alcohol can raise <strong>triglyceride levels</strong> by promoting <strong>hepatic triglyceride synthesis</strong>, but it does not cause <strong>LPL deficiency</strong>.</li>\r\n<li>Alcohol's effect on lipid metabolism is related to <strong>increased synthesis</strong>, not impaired <strong>triglyceride breakdown</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Hypothyroidism:</strong>\r\n<ul>\r\n<li>Hypothyroidism is associated with <strong>elevated triglycerides</strong>, <strong>fatigue</strong>, and <strong>weight gain</strong>, but it <strong>does not cause LPL deficiency</strong>.</li>\r\n<li><strong>Hypothyroidism</strong> affects metabolism and lipid metabolism but does not directly influence <strong>LPL enzyme activity</strong>.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option B: Excessive carbohydrate intake</strong>\r\n<ul>\r\n<li>Carbohydrate intake can contribute to elevated triglycerides, but it <strong>does not cause a deficiency</strong> in <strong>LPL activity</strong>.</li>\r\n<li><strong>LPL deficiency</strong> is specifically <strong>genetic</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option C: Alcohol consumption</strong>\r\n<ul>\r\n<li>Alcohol raises triglyceride levels by increasing <strong>hepatic triglyceride synthesis</strong>, not by affecting <strong>LPL activity</strong>.</li>\r\n<li><strong>LPL deficiency</strong> is not linked to alcohol consumption.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option D: Hypothyroidism</strong>\r\n<ul>\r\n<li>Hypothyroidism leads to elevated triglycerides but does not directly affect <strong>LPL</strong> activity.</li>\r\n<li><strong>LPL deficiency</strong> is a <strong>genetic</strong> condition, not related to hypothyroidism.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Lipoprotein lipase (LPL) deficiency</strong> is caused by a <strong>genetic mutation</strong> in the <strong>LPL gene</strong>.</li>\r\n<li>The deficiency leads to <strong>high triglyceride levels</strong> as <strong>LPL</strong> is responsible for breaking down triglycerides in lipoproteins.</li>\r\n<li>Symptoms of <strong>LPL deficiency</strong> include <strong>fatigue</strong>, <strong>weight gain</strong>, and <strong>elevated triglycerides</strong> despite dietary control.</li>\r\n</ul>",
      "correct_choice_id": 161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Free fatty acids</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Phospholipids</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Triglycerides</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholesterol esters</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young woman complains of abdominal pain and yellowish lesions on her skin. Laboratory tests indicate high levels of cholesterol and triglycerides. Which type of lipid is most likely accumulated in her body?</span></p>",
      "unique_key": "DT1295890",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295890,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Triglycerides:</strong>\r\n<ul>\r\n<li><strong>Triglycerides</strong> are the primary type of fat found in the blood and are <strong>likely elevated</strong> in this patient.</li>\r\n<li><strong>High triglyceride levels</strong> can cause <strong>abdominal pain</strong>, often due to pancreatitis, and lead to <strong>yellowish skin lesions</strong> known as <strong>xanthomas</strong> (fat deposits under the skin).</li>\r\n<li>This condition aligns with the clinical presentation of <strong>yellowish lesions</strong> and <strong>high triglyceride levels</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Free fatty acids:</strong>\r\n<ul>\r\n<li><strong>Free fatty acids</strong> are unesterified fats circulating in the bloodstream, primarily used as an energy source.</li>\r\n<li>They are not typically linked with <strong>yellowish lesions</strong> (such as xanthomas) or <strong>high triglyceride levels</strong> as described in this case.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Phospholipids:</strong>\r\n<ul>\r\n<li><strong>Phospholipids</strong> are components of <strong>cell membranes</strong> and <strong>lipoproteins</strong>.</li>\r\n<li>They do not accumulate in the body in cases of <strong>hyperlipidemia</strong> and are not typically associated with <strong>abdominal pain</strong> or <strong>yellowish skin lesions</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Cholesterol esters:</strong>\r\n<ul>\r\n<li><strong>Cholesterol esters</strong> are a storage form of <strong>cholesterol</strong> found within <strong>lipoproteins</strong>.</li>\r\n<li>Although high cholesterol levels may be present, <strong>elevated triglycerides</strong> are more strongly associated with the clinical symptoms of <strong>abdominal pain</strong> and <strong>xanthomas</strong>.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A: Free fatty acids</strong>\r\n<ul>\r\n<li><strong>Free fatty acids</strong> are not associated with the <strong>accumulation of fat</strong> leading to <strong>xanthomas</strong>.</li>\r\n<li>They are used as an energy source, not stored in skin lesions like <strong>xanthomas</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option B: Phospholipids</strong>\r\n<ul>\r\n<li><strong>Phospholipids</strong> do not accumulate in cases of <strong>hyperlipidemia</strong> and are not linked to <strong>yellowish lesions</strong> or <strong>abdominal pain</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option D: Cholesterol esters</strong>\r\n<ul>\r\n<li><strong>Cholesterol esters</strong> are involved in <strong>lipoproteins</strong> but are less likely to be the cause of <strong>yellowish skin lesions</strong> or <strong>abdominal pain</strong> compared to <strong>triglycerides</strong>.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Xanthomas</strong> are lipid-filled foam cells in the skin or tendons, commonly linked to <strong>hyperlipidemia</strong> such as <strong>familial hypercholesterolemia</strong> or <strong>hypertriglyceridemia</strong>.</li>\r\n<li><strong>Xanthelasma</strong>, a common type of xanthoma, presents as yellow plaques, usually on the <strong>eyelids</strong>, and can be associated with <strong>high cholesterol</strong>.</li>\r\n<li>Treatment involves managing the <strong>underlying lipid disorder</strong>, with cosmetic removal options for lesions.</li>\r\n</ul>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Monounsaturated fatty acids</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Polyunsaturated fatty acids</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Saturated fatty acids</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An elderly patient presents with signs of atherosclerosis. His diet is high in saturated fats, and lab tests show elevated LDL levels. Which type of fatty acid is primarily associated with increased cardiovascular risk?</span></p>",
      "unique_key": "DT1295893",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295893,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Saturated fatty acids:</strong>\r\n<ul>\r\n<li><strong>Saturated fatty acids</strong>, found in animal products (like red meat, butter, and cheese) and tropical oils (such as coconut and palm oil), are <strong>primarily associated</strong> with <strong>increased cardiovascular risk</strong>.</li>\r\n<li>They raise <strong>LDL (bad)</strong> cholesterol levels, which contribute to <strong>atherosclerosis</strong> (plaque buildup in the arteries), increasing the risk of heart disease.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Monounsaturated fatty acids:</strong>\r\n<ul>\r\n<li><strong>Monounsaturated fatty acids</strong>, found in foods like olive oil, avocados, and nuts, are <strong>heart-healthy</strong>.</li>\r\n<li>They can <strong>lower LDL cholesterol</strong> and <strong>reduce cardiovascular risk</strong> when replacing <strong>saturated fats</strong> in the diet.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Polyunsaturated fatty acids:</strong>\r\n<ul>\r\n<li><strong>Polyunsaturated fatty acids</strong>, found in foods like fish, flaxseeds, and walnuts, are also <strong>heart-protective</strong>.</li>\r\n<li>Certain types, like <strong>omega-3 fatty acids</strong>, have <strong>anti-inflammatory effects</strong> and lower the risk of <strong>cardiovascular disease</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>All of the above:</strong>\r\n<ul>\r\n<li>While <strong>saturated fats</strong> are linked to increased cardiovascular risk, <strong>monounsaturated</strong> and <strong>polyunsaturated fats</strong> are generally <strong>heart-healthy</strong>.</li>\r\n<li>This makes <strong>all of the above</strong> incorrect in the context of <strong>increased cardiovascular risk</strong>.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>Option A: Monounsaturated fatty acids</strong>\r\n<ul>\r\n<li><strong>Monounsaturated fats</strong> are <strong>heart-healthy</strong> and can lower <strong>LDL cholesterol</strong>, which <strong>reduces cardiovascular risk</strong>, not increases it.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option B: Polyunsaturated fatty acids</strong>\r\n<ul>\r\n<li><strong>Polyunsaturated fats</strong> have protective effects, such as reducing <strong>inflammation</strong> and <strong>triglycerides</strong>, thereby <strong>reducing cardiovascular risk</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Option D: All of the above</strong>\r\n<ul>\r\n<li>While <strong>saturated fats</strong> increase cardiovascular risk, <strong>monounsaturated</strong> and <strong>polyunsaturated fats</strong> are beneficial and do not contribute to <strong>atherosclerosis</strong> or <strong>increased LDL levels</strong>.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Saturated fats</strong> are linked to <strong>increased cardiovascular risk</strong> due to their role in raising <strong>LDL cholesterol</strong>.</li>\r\n<li><strong>Monounsaturated</strong> and <strong>polyunsaturated fats</strong> have <strong>heart-protective effects</strong>, reducing <strong>LDL cholesterol</strong> and <strong>inflammation</strong>.</li>\r\n<li><strong>Trans fatty acids</strong> (found in processed foods) should be avoided as they <strong>raise LDL cholesterol</strong> and lower <strong>HDL cholesterol</strong>, increasing <strong>cardiovascular risk</strong>.</li>\r\n</ul>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">HMG co A synthase inhibitors are very effective in reducing cholesterol level in the blood</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">To keep LDL cholesterol below 230 is advisable to prevent atherosclerosis</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Probucol increases LDL catabolism and prevents atherosclerosis</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">There is less chances of atherosclerosis in tangier disease.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the true statement about hyperlipidemia</span></p>",
      "unique_key": "DT1295895",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295895,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Probucol</strong> increases LDL catabolism by decreasing its production in the liver and enhancing its uptake. This helps prevent oxidation and atherosclerosis, although it is less commonly used today due to its side effect of reducing HDL cholesterol.</li>\r\n<li><strong>HMG-CoA reductase inhibitors (statins)</strong> are effective in reducing cholesterol levels, not HMG-CoA synthase inhibitors, which are involved in ketone production, not cholesterol synthesis.</li>\r\n<li><strong>LDL cholesterol levels</strong> should ideally be kept below 100 mg/dL (for high-risk individuals), not 230 mg/dL, to effectively reduce the risk of atherosclerosis.</li>\r\n<li><strong>Tangier disease</strong> leads to extremely low HDL cholesterol levels, increasing cardiovascular risk, rather than protecting against atherosclerosis.</li>\r\n</ul>\r\n<p><strong>Why Not Others</strong>:</p>\r\n<ul>\r\n<li><strong>Option A</strong>: HMG-CoA <strong>synthase</strong> inhibitors are not used for cholesterol reduction; HMG-CoA <strong>reductase</strong> inhibitors (statins) are the correct choice for lowering cholesterol levels.</li>\r\n<li><strong>Option B</strong>: LDL cholesterol should be below <strong>100 mg/dL</strong>, not 230 mg/dL, to reduce the risk of atherosclerosis.</li>\r\n<li><strong>Option D</strong>: <strong>Tangier disease</strong> results in very low HDL cholesterol, which actually increases the risk of atherosclerosis, rather than decreasing it.</li>\r\n</ul>\r\n<p><strong>Key Takeaways</strong>:</p>\r\n<ul>\r\n<li><strong>Statins</strong>: Inhibit HMG-CoA reductase, reducing cholesterol synthesis.</li>\r\n<li><strong>Fibrates</strong>: Activate PPAR-&alpha;, enhancing fatty acid oxidation and lowering triglycerides.</li>\r\n<li><strong>Bile Acid Sequestrants</strong>: Bind bile acids, lowering LDL cholesterol.</li>\r\n<li><strong>Niacin</strong>: Reduces triglycerides and LDL, raises HDL cholesterol.</li>\r\n</ul>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Fatty acid synthesis</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Fatty acid oxidation</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Lipoprotein synthesis</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholesterol synthesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with muscle weakness and elevated creatine kinase levels. Biochemical analysis reveals a deficiency in carnitine acyltransferase. Which metabolic process is primarily affected?</span></p>",
      "unique_key": "DT1295896",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295896,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Fatty acid oxidation</strong> is the primary process affected by a deficiency in <strong>carnitine acyltransferase</strong>. This enzyme is essential for transporting long-chain fatty acids into the mitochondria for &beta;-oxidation, which produces energy. Without it, fatty acids cannot be metabolized efficiently, leading to muscle weakness and elevated creatine kinase levels due to muscle damage from energy deprivation.</li>\r\n<li><strong>Fatty acid synthesis</strong> is not affected, as it involves a different pathway (fatty acid synthase), and does not depend on carnitine acyltransferase.</li>\r\n<li><strong>Lipoprotein synthesis</strong> is unrelated to carnitine acyltransferase. It involves apolipoproteins and other processes, but not fatty acid transport or oxidation.</li>\r\n<li><strong>Cholesterol synthesis</strong> involves enzymes like HMG-CoA reductase and is independent of carnitine acyltransferase.</li>\r\n</ul>\r\n<p><strong>Why Not Others</strong>:</p>\r\n<ul>\r\n<li><strong>Option A</strong>: Fatty acid <strong>synthesis</strong> involves fatty acid synthase, not carnitine acyltransferase, so it is unaffected.</li>\r\n<li><strong>Option C</strong>: Lipoprotein <strong>synthesis</strong> is not directly impacted by carnitine acyltransferase deficiency.</li>\r\n<li><strong>Option D</strong>: Cholesterol <strong>synthesis</strong> is unrelated to carnitine acyltransferase and relies on HMG-CoA reductase for its regulation.</li>\r\n</ul>\r\n<p><strong>Key Takeaways</strong>:</p>\r\n<ul>\r\n<li><strong>Fatty acid oxidation</strong> is essential for energy production, especially during fasting or prolonged exercise.</li>\r\n<li><strong>Carnitine acyltransferase</strong> is crucial for transporting fatty acids into the mitochondria for oxidation.</li>\r\n<li>Disorders like <strong>Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)</strong> can impair fatty acid oxidation, leading to metabolic complications such as hypoglycemia.</li>\r\n</ul>",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Viral hepatitis</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcohol consumption</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Obesity</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Medications</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most common cause of fatty liver disease in adults?</span></p>",
      "unique_key": "DT1295898",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295898,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Alcohol consumption</strong> is the most common cause of fatty liver disease, specifically <strong>alcoholic fatty liver disease (AFLD)</strong>, where excessive alcohol intake leads to fat accumulation in the liver.</li>\r\n<li><strong>Viral hepatitis</strong> (e.g., hepatitis B or C) can cause liver damage but is not the most common cause of fatty liver disease.</li>\r\n<li><strong>Obesity</strong> is a common cause of <strong>non-alcoholic fatty liver disease (NAFLD)</strong>, especially when associated with conditions like insulin resistance and metabolic syndrome, but alcohol remains the leading cause.</li>\r\n<li><strong>Medications</strong> (e.g., corticosteroids, some antiretrovirals, and chemotherapeutic agents) can contribute to fatty liver but are not as common as alcohol consumption.</li>\r\n</ul>\r\n<p><strong>Why Not Others</strong>:</p>\r\n<ul>\r\n<li><strong>Option A</strong>: <strong>Viral hepatitis</strong> may lead to liver disease but is not the primary cause of fatty liver.</li>\r\n<li><strong>Option C</strong>: <strong>Obesity</strong> is a common cause of NAFLD but does not surpass alcohol as the leading cause.</li>\r\n<li><strong>Option D</strong>: Medications contribute to liver fat accumulation but are not the most common cause of fatty liver disease.</li>\r\n</ul>\r\n<p><strong>Key Takeaways</strong>:</p>\r\n<ul>\r\n<li><strong>Fatty liver disease</strong> involves excess fat accumulation in liver cells, classified as alcoholic (AFLD) or non-alcoholic (NAFLD).</li>\r\n<li><strong>Alcohol</strong> is the leading cause of fatty liver disease.</li>\r\n<li><strong>Lipotropic factors</strong> (e.g., Choline, Inositol, Methionine, Vitamin B12) promote the removal of fat from the liver and support normal liver function.</li>\r\n</ul>",
      "correct_choice_id": 212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum albumin</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Alanine aminotransferase (ALT)</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Total cholesterol</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemoglobin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which laboratory finding is commonly elevated in patients with alcoholic fatty liver disease?</span></p>",
      "unique_key": "DT1295899",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295899,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>ALT</strong> (Alanine aminotransferase) is an enzyme primarily found in the liver and is elevated in alcoholic fatty liver disease. ALT levels rise due to liver cell damage, though it is typically less elevated than <strong>AST</strong> (aspartate aminotransferase). A common feature in alcoholic liver disease is an <strong>AST/ALT ratio</strong> greater than 2:1.</li>\r\n<li><strong>Serum albumin</strong> reflects the liver's synthetic function. In early-stage alcoholic fatty liver disease, serum albumin levels remain normal or mildly affected.</li>\r\n<li><strong>Total cholesterol</strong> may be influenced by liver function, but it does not consistently increase in alcoholic fatty liver disease and is not a reliable marker for it.</li>\r\n<li><strong>Hemoglobin</strong> measures red blood cells, and although alcoholism may lead to anemia, hemoglobin levels are not typically elevated in alcoholic fatty liver disease.</li>\r\n</ul>\r\n<p><strong>Why Not Others</strong>:</p>\r\n<ul>\r\n<li><strong>Option A</strong>: <strong>Serum albumin</strong> is generally normal in early-stage alcoholic fatty liver disease and declines in advanced liver disease.</li>\r\n<li><strong>Option C</strong>: <strong>Total cholesterol</strong> levels do not consistently rise in alcoholic fatty liver disease.</li>\r\n<li><strong>Option D</strong>: <strong>Hemoglobin</strong> is not elevated in alcoholic fatty liver disease, though anemia can occur in advanced stages.</li>\r\n</ul>\r\n<p><strong>Key Takeaways</strong>:</p>\r\n<ul>\r\n<li><strong>ALT</strong> is commonly elevated in alcoholic fatty liver disease, with AST often being higher, leading to the characteristic <strong>AST/ALT ratio &gt; 2:1</strong> in alcohol-related liver conditions.</li>\r\n</ul>",
      "correct_choice_id": 222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">CT scan</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Ultrasound</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">X-ray</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What imaging modality is commonly used to assess fatty liver?</span></p>",
      "unique_key": "DT1295900",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295900,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Ultrasound</strong> is the <strong>most commonly used imaging modality</strong> for diagnosing fatty liver due to its <strong>non-invasive nature</strong>, <strong>wide availability</strong>, and <strong>low cost</strong>. It shows fatty liver as a <strong>brighter (hyperechoic)</strong> liver compared to the kidneys, which indicates the presence of fat. Though it <strong>cannot quantify fat content</strong> or assess <strong>liver fibrosis severity</strong>, it is <strong>sufficient for diagnosing fatty liver</strong> in routine clinical practice.</li>\r\n<li><strong>CT scan</strong> can detect fatty liver by showing a <strong>reduction in liver density</strong> due to fat accumulation. However, <strong>radiation exposure</strong> limits its use, and it is typically reserved for evaluating <strong>complications</strong> or the <strong>extent of liver damage</strong> rather than for initial screening.</li>\r\n<li><strong>MRI</strong> is highly sensitive and provides detailed images of liver tissue. Using <strong>MRI-PDFF (proton density fat fraction)</strong> and <strong>MR spectroscopy</strong>, it can <strong>quantify liver fat</strong> accurately, making it ideal for <strong>advanced cases</strong> or research. However, due to its <strong>cost</strong>, <strong>limited availability</strong>, and longer procedure time, it is not commonly used for <strong>initial assessment</strong> of fatty liver.</li>\r\n<li><strong>X-ray</strong> provides limited soft tissue detail and is <strong>not useful for assessing fatty liver</strong>, as it cannot differentiate between normal liver tissue and fat accumulation. It is used primarily for <strong>bone</strong>, <strong>chest</strong>, or <strong>abdominal imaging</strong> but not for liver evaluation.</li>\r\n</ul>\r\n<p><strong>Why Not Others</strong>:</p>\r\n<ul>\r\n<li><strong>Option A</strong>: <strong>CT scan</strong> exposes the patient to radiation and is more expensive than ultrasound, making it less ideal for initial screening of fatty liver.</li>\r\n<li><strong>Option B</strong>: <strong>MRI</strong> offers detailed imaging but is <strong>more expensive</strong>, less widely available, and generally used for further evaluation when more information is needed.</li>\r\n<li><strong>Option D</strong>: <strong>X-ray</strong> does not provide adequate resolution to assess fatty liver and is therefore not suitable for liver evaluation.</li>\r\n</ul>\r\n<p><strong>Key Takeaways</strong>:</p>\r\n<ul>\r\n<li><strong>Ultrasound</strong> remains the <strong>first-line imaging modality</strong> for fatty liver due to its <strong>non-invasive</strong>, <strong>quick</strong>, and <strong>cost-effective</strong> nature.</li>\r\n<li>While <strong>CT scan</strong> and <strong>MRI</strong> are more detailed, they are generally reserved for cases requiring further investigation or quantification of liver damage.</li>\r\n<li><strong>X-ray</strong> is <strong>not applicable</strong> for evaluating fatty liver.</li>\r\n</ul>",
      "correct_choice_id": 233,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphatidylinositol</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphatidylcholine</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphatidylethanolamine</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphatidylserine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which phospholipid is known for its role in cell signalling and membrane dynamics?</span></p>",
      "unique_key": "DT1295903",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295903,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Phosphatidylinositol (PI)</strong> is crucial for <strong>cell signaling</strong> and <strong>membrane dynamics</strong>. It is involved in <strong>signaling pathways</strong>, <strong>membrane anchoring</strong>, and the regulation of the <strong>cytoskeleton</strong>, making it essential for cellular communication and structural integrity.</li>\r\n<li><strong>Phosphatidylcholine (PC)</strong> is the <strong>most abundant phospholipid</strong> in cell membranes, primarily responsible for <strong>membrane integrity</strong> and <strong>lipid transport</strong>. It also acts as a <strong>lung surfactant</strong> (Dipalmitoyl phosphatidyl choline) to reduce surface tension in the lungs.</li>\r\n<li><strong>Phosphatidylethanolamine (PE)</strong> plays a role in <strong>membrane fusion</strong> and <strong>cell division</strong>. It is also important in the <strong>nervous system</strong> and contributes to <strong>blood coagulation</strong> as a component of thromboplastin.</li>\r\n<li><strong>Phosphatidylserine (PS)</strong> is involved in <strong>apoptosis signaling</strong>, <strong>blood clotting</strong>, and <strong>neuronal function</strong>. It is especially important for the regulation of <strong>cell death</strong> and <strong>cognitive health</strong>.</li>\r\n</ul>\r\n<p><strong>Why Not Others</strong>:</p>\r\n<ul>\r\n<li><strong>Option B</strong>: <strong>Phosphatidylcholine</strong> is mainly involved in maintaining membrane integrity, but it is not primarily responsible for <strong>signaling</strong> or <strong>membrane dynamics</strong>.</li>\r\n<li><strong>Option C</strong>: <strong>Phosphatidylethanolamine</strong> is key for <strong>membrane fusion</strong> and <strong>cell division</strong>, but it does not play as direct a role in <strong>signaling</strong> or <strong>membrane anchoring</strong> as PI.</li>\r\n<li><strong>Option D</strong>: <strong>Phosphatidylserine</strong> is important for <strong>apoptosis</strong> and <strong>clotting</strong>, but it is not primarily involved in <strong>signaling</strong> or <strong>cytoskeleton regulation</strong> like PI.</li>\r\n</ul>\r\n<p><strong>Key Takeaways</strong>:</p>\r\n<ul>\r\n<li><strong>Phosphatidylinositol (PI)</strong> is essential for <strong>cell signaling</strong>, <strong>membrane anchoring</strong>, and <strong>cytoskeleton regulation</strong>.</li>\r\n<li><strong>Phosphatidylcholine</strong> is the most abundant phospholipid in cell membranes and plays a major role in <strong>lung surfactant</strong>.</li>\r\n<li><strong>Cardiolipin</strong> is crucial for <strong>mitochondrial function</strong> and <strong>energy production</strong>.</li>\r\n<li><strong>Phosphatidylserine</strong> is essential for <strong>apoptosis signaling</strong> and <strong>blood clotting</strong>.</li>\r\n</ul>",
      "correct_choice_id": 241,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Foam cells</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">High cholesterol level</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Uncontrolled diabetes mellitus</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the hallmark of atherosclerotic plaque?</span></p>",
      "unique_key": "DT1295904",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295904,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Foam cells</strong> are the hallmark of <strong>atherosclerotic plaque</strong>. They are macrophages that ingest <strong>oxidized LDL</strong> (low-density lipoprotein) cholesterol, leading to the accumulation of lipid-laden, \"foamy\" macrophages in the <strong>arterial walls</strong>. These foam cells release <strong>inflammatory signals</strong> and contribute to <strong>plaque growth</strong>, which forms the core of the atherosclerotic plaque. Their presence is a <strong>key indicator</strong> of <strong>atherosclerosis progression</strong>.</li>\r\n<li><strong>High cholesterol levels</strong>, especially <strong>LDL cholesterol</strong>, are a significant risk factor for atherosclerosis. They promote the formation of foam cells, but they are not the hallmark of the plaque itself.</li>\r\n<li><strong>Uncontrolled diabetes mellitus</strong> accelerates atherosclerosis by causing <strong>oxidative stress</strong>, <strong>inflammation</strong>, and <strong>endothelial dysfunction</strong>. However, it is not the hallmark of the plaque formation, although it is strongly associated with plaque progression.</li>\r\n<li><strong>Option D</strong>: While both high cholesterol and diabetes contribute to atherosclerosis, <strong>foam cells</strong> are the hallmark feature of the plaque.</li>\r\n</ul>\r\n<p><strong>Why Not Others</strong>:</p>\r\n<ul>\r\n<li><strong>Option B</strong>: <strong>High cholesterol</strong> contributes to foam cell formation but is not the hallmark of the plaque.</li>\r\n<li><strong>Option C</strong>: <strong>Uncontrolled diabetes</strong> accelerates atherosclerosis but is not a defining feature of the plaque.</li>\r\n<li><strong>Option D</strong>: Although <strong>high cholesterol</strong> and <strong>diabetes</strong> are important risk factors, <strong>foam cells</strong> are the hallmark feature in atherosclerotic plaques.</li>\r\n</ul>\r\n<p><strong>Key Takeaways</strong>:</p>\r\n<ul>\r\n<li><strong>Foam cells</strong> are the main component of <strong>atherosclerotic plaques</strong> formed from <strong>oxidized LDL</strong> uptake by macrophages.</li>\r\n<li><strong>Atherosclerosis</strong> progression involves <strong>lipid accumulation</strong>, <strong>inflammation</strong>, and <strong>endothelial dysfunction</strong>.</li>\r\n<li><strong>HDL</strong> (high-density lipoprotein) helps protect against atherosclerosis by removing cholesterol from arterial walls.</li>\r\n</ul>",
      "correct_choice_id": 251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}